BioSpace News Archive

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced results from a planned interim analysis of the Phase 3 RATIONALE 303 trial of its anti-PD-1 antibody tislelizumab compared to docetaxel as second- or third-line therapy for patients with locally advanced or metastatic non-small cell lung cancer

Tevogen Bio, a pioneering immunotherapy company, announces that Dr. Neal Flomenberg, MD, Professor and Chairman of the Department of Medical Oncology at Thomas Jefferson University, will present preclinical data of TVGN-489, Tevogen’s investigational allogeneic cytotoxic T cell therapy for COVID-19 at the 2021 Annual Meeting of the American Association of Immunologists (AAI)

FDA Quality and Regulatory Consultants rolls out a revamped company website.

Livanta LLC is pleased to announce its recent award of a national claim review task order under the Centers for Medicare & Medicaid Services’ Beneficiary and Family Centered Care - Quality Improvement Organization program.

Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2021 after market close on Wednesday, May 5, 2021.

Replimune Group announced data during two presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021 being held virtually April 10-15, 2021 and May 17-21, 2021.

Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 10, 2021. Company management will host a corresponding conferenc

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2021 after market close on Thursday, May 6, 2021.

Senior Executive from Abbott Laboratories Latin American EPD Division to Accelerate Procaps Group’s Rollout of Global Growth Initiatives & Strengthen Its Management Team

Children’s Hospital of Philadelphia announced the opening of a new, 37,000-square-foot Specialty Care Center in Abington, PA.